MSON

Bioventus Scoops Up Misonix In $518M Stock & Cash Deal; Raises FY21 Sales Outlook

Misonix Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Misonix, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – MSON

Misonix Appoints Patrick J. Beyer to Board of Directors

Misonix to Participate in Upcoming May and June Virtual Investor Conferences

Misonix, Inc. (MSON) CEO Stavros Vizirgianakis on Q3 2021 Results - Earnings Call Transcript

Misonix to Report Fiscal 2021 Third Quarter Financial Results and Host Conference Call and Webcast on May 6

Misonix Expands Ultrasonic Technology Capabilities to Address the Orthoplastics Market